Consensus Nykode Therapeutics

Equities

VACC

NO0010714785

Market Closed - Oslo Bors Other stock markets 08:15:00 29/04/2024 pm IST			5-day change	1st Jan Change
13.24 ^NOK	+2.00%		+0.61%	-38.13%

19/04	Nykode Therapeutics Launches Phase 2 Clinical Trial for Cervical Cancer Vaccine	MT
19/04	Nykode Therapeutics ASA Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer	CI

Evolution of the average Target Price on Nykode Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

143052ca2142fea4bb30223ae81dce.ncnNX4qMb4wWkubOBrbsC8ngH5MlfUvcgZ3SO1VuNx4.rYP4O-vVDbha3b-RM9HcWoeZS_FkPjOvuNGcVGIGejPsqpoo_d8Y2UXqpw~fb3d463d9365436bacd0d63cf05f4b32